IRIS Accounts Production v23.3.0.418 11620159 Board of Directors 1.4.22 31.3.23 31.3.23 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh116201592022-03-31116201592023-03-31116201592022-04-012023-03-31116201592021-03-31116201592021-04-012022-03-31116201592022-03-3111620159ns10:Originalns15:EnglandWales2022-04-012023-03-3111620159ns14:PoundSterlingns10:Original2022-04-012023-03-3111620159ns10:Originalns10:Director12022-04-012023-03-3111620159ns10:Original2022-04-012023-03-3111620159ns10:Original2023-03-3111620159ns10:Originalns10:PrivateLimitedCompanyLtd2022-04-012023-03-3111620159ns10:Originalns10:Micro-entities2022-04-012023-03-3111620159ns10:Originalns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3111620159ns10:Originalns10:FullAccounts2022-04-012023-03-3111620159ns10:EntityHasNeverTradedns10:Original2022-04-012023-03-3111620159ns10:Original2022-03-3111620159ns10:Originalns5:CurrentFinancialInstruments2023-03-3111620159ns10:Originalns5:CurrentFinancialInstruments2022-03-3111620159ns10:Originalns10:RegisteredOffice2022-04-012023-03-3111620159ns10:Original2021-04-012022-03-31
REGISTERED NUMBER: 11620159 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2023

FOR

DAN BLACKMAN CARDIOLOGY LTD

DAN BLACKMAN CARDIOLOGY LTD (REGISTERED NUMBER: 11620159)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023




Page

Balance Sheet 1


DAN BLACKMAN CARDIOLOGY LTD (REGISTERED NUMBER: 11620159)

BALANCE SHEET
31 MARCH 2023

31.3.23 31.3.22
£    £   
CALLED UP SHARE CAPITAL NOT PAID 5 100

CURRENT ASSETS 66,348 41,048

CREDITORS
Amounts falling due within one year (13,044 ) (11,388 )
NET CURRENT ASSETS 53,304 29,660
TOTAL ASSETS LESS CURRENT
LIABILITIES

53,309

29,760

ACCRUALS AND DEFERRED INCOME 2,860 2,786
NET ASSETS 50,449 26,974

CAPITAL AND RESERVES 50,449 26,974

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

Dan Blackman Cardiology Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 11620159

Registered office: 269 High Street
Boston Spa
West Yorkshire
LS23 6AL

The presentation currency of the financial statements is the Pound Sterling, which is the functional currency of the company, rounded to the nearest £1.

2. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 2 (2022 - 2 ) .

3. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

During the year monies totalling £572 (2022: £2,672) were received from the director and £121 (2022: £112) was repaid to the director. At the year end an amount of £1,002 (2022: £551) remained due to the director.



DAN BLACKMAN CARDIOLOGY LTD (REGISTERED NUMBER: 11620159)

BALANCE SHEET - continued
31 MARCH 2023


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 6 November 2023 and were signed on its behalf by:





Dr D Blackman - Director